A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma
Clinical trial NCT07115550 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07115550
- Sponsor
- Huai'an First People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-26
- Primary completion
- 2027-08-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.